Based on research
Intelligent product development
Medela invests in research projects and scientific studies. The development of Thopaz was accompanied by an international, randomized, controlled clinical study at four well-known thoracic clinics. The results confirm that Thopaz offers state-of-the-art thoracic drainage an efficient and comfortable, alternative to standard treatment.
- The great efficiency of the Thopaz system for thoracic drainage clearly proven
The results of the study prove the great efficiency of the mobile Thopaz system with a 5 l/min flow performance.
- Greater mobility compared to patients who received conventional treatment
The patients who were treated with the Thopaz system had a greater degree of mobility than the control group. They performed more activities outside the patient room and for longer periods of time. The outcome heightened patient satisfaction.
- Greater nursing staff satisfaction
Physicians and nursing staff were more satisfied with the Thopaz system, primarily with regard to the handling of the system and the reduced workload.